Febrile neutropenia
DOI:
https://doi.org/10.32818/reccmi.a5n1a15Keywords:
febrile neutropenia, MASCC, Talcott, CISNE, outpatient treatment.Abstract
Most chemotherapy treatments have a negative effect in myelopoiesis and the integrity of gastrointestinal mucous membranes, increasing the risk of invasive translocation infections of bacteria and/or fungi. Neutropenic fever is a serious complication; its mortality rate varies from 11 % to 50 % in the case of severe sepsis or septic shock. It is essential to recognize this early and start empirical antibacterial therapy immediately. In patients with good prognosis criteria, outpatient treatment is an option to consider.
Downloads
Metrics
References
Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol. 2018 May 10; 36(14): 1443-1453. https://doi.org/10.1200/JCO.2017.77.6211.
Fonseca PJ, Carmona-Bayonas A, García IM, Marcos R, Castañón E, Antonio M, et al. A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia. Br J Cancer. 2016 May 24; 114(11): 1191-1198. https://doi.org/10.1038/bjc.2016.118.
Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, et al. Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA Clinical Practice Guideline Update. J Clin Oncol. 2018 Oct 20; 36(30): 3043-3054. https://doi.org/10.1200/JCO.18.00374.
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011 Feb 15; 52(4): e56-93. https://doi.org/10.1093/cid/cir073.
Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, et al. prevention and treatment of cancer-related infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 Jul; 14(7): 882-913. https://doi.org/10.6004/jnccn.2016.0093.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 María Mar Cutillas-Pérez, Cristina Macía-Rodríguez, Lucía Santomé-Couto, Javier de-la-Fuente-Aguado
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
